High Tide (NASDAQ:HITI) and Avivagen (OTCMKTS:VIVXF) Financial Comparison

Avivagen (OTCMKTS:VIVXF) and High Tide (NASDAQ:HITI) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Analyst Ratings

This is a summary of current ratings and price targets for Avivagen and High Tide, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avivagen	0	0	0	0	0.00
High Tide	1	0	3	1	2.80

High Tide has a consensus target price of $6.13, indicating a potential upside of 171.02%. Given High Tide’s stronger consensus rating and higher probable upside, analysts plainly believe High Tide is more favorable than Avivagen.

Earnings & Valuation

This table compares Avivagen and High Tide”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avivagen	N/A	N/A	N/A	($0.04)	N/A
High Tide	$425.10 million	0.47	-$36.23 million	($0.34)	-6.65

Avivagen has higher earnings, but lower revenue than High Tide. High Tide is trading at a lower price-to-earnings ratio than Avivagen, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Avivagen and High Tide’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Avivagen	N/A	N/A	N/A
High Tide	-7.53%	0.58%	0.24%

Institutional & Insider Ownership

4.5% of High Tide shares are held by institutional investors. 2.1% of Avivagen shares are held by company insiders. Comparatively, 12.4% of High Tide shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

High Tide beats Avivagen on 9 of the 11 factors compared between the two stocks.

About Avivagen

Avivagen Inc. focuses on developing and commercializing products for livestock feeds that support immune function and help animals to achieve their growth and productivity. The company offers OxC-beta Livestock, a premix for inclusion in livestock feeds; Vivamune health chews for dogs; Dr. Tobias dog chews; and Dr. Tobias Beta blend for the human immune system. It serves in Canada, Mexico, Brazil, the Philippines, Taiwan, and Thailand. Avivagen Inc. was incorporated in 2005 and is headquartered in Ottawa, Canada.

About High Tide

High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. It operates licensed retail cannabis stores; and provides data analytics services. In addition, the company manufactures and distributes consumption accessories. Further, it sells its products through online sales via e-commerce platform. The company offers its products under the Daily High Club, DankStop, FABCBD, GC, Nuleaf, Smoke Cartel, and Blessed CBD brands. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. High Tide Inc. was founded in 2009 and is headquartered in Calgary, Canada.